Diabetes mellitus and the peripheral nervous system: Manifestations and mechanisms
- 27 April 2007
- journal article
- review article
- Published by Wiley in Muscle & Nerve
- Vol. 36 (2) , 144-166
- https://doi.org/10.1002/mus.20785
Abstract
Diabetes targets the peripheral nervous system with several different patterns of damage and several mechanisms of disease. Diabetic polyneuropathy (DPN) is a common disorder involving a large proportion of diabetic patients, yet its pathophysiology is controversial. Mechanisms considered have included polyol flux, microangiopathy, oxidative stress, abnormal signaling from advanced glycation endproducts and growth factor deficiency. Although some clinical trials have demonstrated modest benefits in disease stabilization or pain therapy in DPN, robust therapy capable of reversing the disease is unavailable. In this review, general aspects of DPN and other diabetic neuropathies are examined, including a summary of recent therapeutic trials. A particular emphasis is placed on the evidence that the neurobiology of DPN reflects a unique yet common and disabling neurodegenerative disorder. Muscle Nerve, 2007Keywords
This publication has 257 references indexed in Scilit:
- Oxcarbazepine in painful diabetic neuropathy: results of a dose-ranging studyActa Neurologica Scandinavica, 2006
- PI3K/Akt and apoptosis: size mattersOncogene, 2003
- Abnormal splicing of the leptin receptor in diabetic miceNature, 1996
- Impaired vasoreactivity to nitric oxide in experimental diabetic neuropathyExperimental Neurology, 1995
- Normal blood flow but lower oxygen tension in diabetes of young rats: microenvironment and the influence of sympathectomyCanadian Journal of Physiology and Pharmacology, 1992
- Effects of Pancreatic Transplantation on Diabetic NeuropathyNew England Journal of Medicine, 1990
- Regeneration and Repair of Myelinated Fibers in Sural-Nerve Biopsy Specimens from Patients with Diabetic Neuropathy Treated with SorbinilNew England Journal of Medicine, 1988
- Advanced Glycosylation End Products in Tissue and the Biochemical Basis of Diabetic ComplicationsNew England Journal of Medicine, 1988
- Sorbitol, Phosphoinositides, and Sodium-Potassium-ATPase in the Pathogenesis of Diabetic ComplicationsNew England Journal of Medicine, 1987
- Aldose Reductase Inhibition Improves Nerve Conduction Velocity in Diabetic PatientsNew England Journal of Medicine, 1983